More importantly, introduction of exogenous CDC6 effectively reversed the inhibitory effects of wogonin on DNA replication and DNA damage in RCC cells, indicating that CDC6 is a target of wogonin in RCC cells. This evidence concerns the gene CDC6 and renal cell carcinoma.